PATH and other growth stocks might benefit from a potential FED halt-buy long duration.
PATH is set to benefit from it as it is a revolutionary industry, RPA and the growth rate of its revenues is still above 20%, even though many companies from the industry lost in revenue growth steam.
Technically, it crossed 200MA and consolidated for a while with a potential to break above 20 into 25-28 area.
PATH is set to benefit from it as it is a revolutionary industry, RPA and the growth rate of its revenues is still above 20%, even though many companies from the industry lost in revenue growth steam.
Technically, it crossed 200MA and consolidated for a while with a potential to break above 20 into 25-28 area.